What question did this study set out to answer?

To assess the efficacy and safety of adjunctive inhaled budesonide combined with azithromycin in treating pediatric Mycoplasma pneumonia.

June 14, 2024MedicineOpen Access

Meta-analysis of combined azithromycin and inhaled budesonide treatment for Chinese pediatric patients with mycoplasma pneumonia

View Full Paper

Ask AI

Bookmark

To assess the efficacy and safety of adjunctive inhaled budesonide combined with azithromycin in treating pediatric Mycoplasma pneumonia.
Conducted a systematic review and meta-analysis adhering to PRISMA guidelines across 5 English and 4 Chinese databases through October 31, 2023.
Identified and synthesized data from 24 randomized controlled trials comprising a total of 2,034 pediatric patients.
Adjunctive budesonide significantly improved clinical efficacy across administration routes: intravenous (OR, 0.156; P < .001), sequential (OR, 0.163; P = .001), and oral (OR, 0.139; P < .001).
Combination treatment significantly enhanced pulmonary function (FEV1: WMD, -0.28, P = .001; PEF: WMD, -0.554, P = .002; FVC: WMD, -0.321, P < .001) and lowered inflammatory markers (IL-6: WMD, 4.760, P = .002; CRP: WMD, 5.520, P < .001; TNF-α: WMD, 9.124, P < .001).
Patients receiving the combination therapy experienced shorter fever duration and faster clearance of cough and rales without an increase in adverse events.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Meta-analysis reveals enhanced therapeutic efficacy and reduced inflammation in pediatric mycoplasma pneumonia, indicating improved recovery without increasing adverse events.

Cite This Study

Zhao et al. (2024) studied this question.

synapsesocial.com/papers/6a0340fe59ea043e4c9e49f7 https://doi.org/10.1097/md.0000000000038332

View Full Paper

Ask AI

Bookmark

Implication

Meta-analysis reveals enhanced therapeutic efficacy and reduced inflammation in pediatric mycoplasma pneumonia, indicating improved recovery without increasing adverse events.

Meta-analysis of combined azithromycin and inhaled budesonide treatment for Chinese pediatric patients with mycoplasma pneumonia

Key Points

Discussion

Implication

Cite This Study

Meta-analysis of combined azithromycin and inhaled budesonide treatment for Chinese pediatric patients with mycoplasma pneumonia

Key Points

Discussion

Implication

Cite This Study